Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion

Matching molecularly targeted therapies with cancer subtype-specific gene mutations is revolutionizing oncology care. However, for rare cancers this approach is problematic due to the often poor understanding of the disease's natural history and phenotypic heterogeneity, making treatment of the...

Full description

Bibliographic Details
Main Authors: Sekulic, Aleksandar, Liang, Winnie S, Tembe, Waibhav, Izatt, Tyler, Kruglyak, Semyon, Kiefer, Jeffrey A, Cuyugan, Lori, Zismann, Victoria, Legendre, Christophe, Pittelkow, Mark R, Gohmann, John J, De Castro, Fernando R, Trent, Jeffrey, Carpten, John, Craig, David W, McDaniel, Timothy K
Format: Online
Language:English
Published: BlackWell Publishing Ltd 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367085/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367085/

Similar Items